
A | Sputnik spoke with Dr. D. B. Bhaaskara, CEO of the multinational company Roerich Healthcare, about the current state of pharma trade with Russia.,Sputnik: Can you explain the current state of pharma supplies to Russia?,D. B. Bhaaskara: Currently, pharmaceutical shipments of Indian firms to Russia are at the same level even after the sanctions. But, there are many proposals (supplies) that Russians are not getting from the European Union. Russians are looking for these materials (chemicals, excipients, APIs [Active Pharmaceutical Ingredients]) with several Indian manufacturers. They have to develop links with Indian firms. There are many proposals from Russia - these proposals are under consideration from the Indian side.,Sputnik: There were reports of delayed payments from Russia initially after sanctions. As we see, trade has jumped manifold in the energy and fertilizer sectors. Do you think payment issues have been resolved in other sectors as well?,D. B. Bhaaskara: Several Indian companies have signed contracts in yuan, which means they are ready to receive payment in China's yuan. Still, the preferred mode of settlement is in the Indian rupee. As export procedures closed successfully in USD/euro/INR, Russians set aside yuan contracts.,My company is receiving regular payment without any delay in Indian rupees or USD or sometimes in euros.,Sputnik: What about logistical issues, as sanctions hit the shipping sector?,D. B. Bhaaskara: The logistical issues are still there because few airlines — namely Aeroflot, Emirates, Qatar, and Turkish — are available for transportation. Transportation costs are slightly high because of no regular cargo consignments. They vary between $8-12 per kg compared to $5 per kg in a normal situation.,Cargo sea shipment is still in a mess. The only port in Gujarat accepts Russian shipping. Here again, the container price is very, very high. We have to pay anything between $9,000 - 12,000 for a container. When there was no conflict or sanctions, it was $2,500 per container.,We have tried to send our shipments via Iran. So, from Gujarat port, the shipment reaches an Iranian port, and from there, it goes via road or rail to Moscow. But, it is taking a much longer time. In general, it is supposed to arrive in 30-40 days, but on an experimental basis, some companies sent their materials via the Iran route, [and they are] still on their way even after two months.,Shanghai is very crowded and has also been hit by the pandemic, making it unsuitable for us. So, the only problem right now is logistics; there is no payment issue.,Some Russian companies have an account with European banks operating in Russia dealing in oil and gas payments. Those banks are being used to send money anywhere worldwide, even with sanctions.,Sputnik: Western firms intended to withdraw their operations in Russia in response to Moscow's special military operation. Do you see some significant investments from Indian pharma companies in Russia to fill the vacuum created by the west?,D. B. Bhaaskara: There are long-pending proposals from a couple of governors, such as [in] Volgograd and Kazan, inviting India's major pharma companies to set up manufacturing units in their region. But, due to the pandemic, nothing moved ahead.,A delegation will be going to Russia to explore the opportunities in Russia in July. A few Indian companies, such as Sun Pharma and Advance Pharma, have manufacturing units in Russia doing finished formulations.,Hopefully, some new companies are interested in setting up units there now. But, Russia is looking to scale up raw material manufacturing, e.g., API. For this, much homework related to regulation should be done between the two governments, especially under sanctions.,Also, big companies such as Sun Pharma, Aurbindo, and Dr. Reddy, all with significant exposure to the US market, may try to avoid investing in Russia because they are scared of the risk associated with sanctions.,Medium-scale companies can come forward to set up raw material (API) manufacturing in Russia. However, it is unclear whether Indian workers/professionals can go and work in Russia. Setting up a new unit in unknown topography with a different language and culture is a little complicated. A lot of these questions are unanswered.。 每日商报讯 近日,杭州新能源车主王先生将车驶入临安星港路停车场充电站,他拔下车位后面那台特殊的充电桩电枪,伴随着清脆的“咔嗒”声,电动车与充电桩相连,随后在手机“e充电”App上选择“放电”功能,车子便开始对电网反向送电。“晚上用谷电价格充电,白天反向送电赚补贴,车网互动的活动体验感真不错。”王先生感慨。这种个人车主通过车载锂电池反哺城市电网的充电模式,在杭州已经连续三年在规定时间内开展。“今年活动的最大变化,是从‘集中测试’走向‘常态化运营’。

B | ”国网杭州供电公司所属杭州市新能源汽车服务有限公司相关负责人何雨微表示。今年的活动分为两个阶段:8月18日至20日开展为期三天的旗舰专场,8月21日至9月11日转为常态化运营。与往年相比,整个活动周期大幅延长,参与规模、覆盖车型、应用场景全面升级。

C | 活动期间,广大新能源车主均可前往萧山钱江世纪城公园、富阳区体育中心、临安星港路停车场、杭州石塘公交充电站等4座V2G充电站参与反向放电。如果说前两年是在验证“车能不能向电网放电”的技术可行性,那么今年的常态化运营则是在验证“车主愿不愿持续放电、电网能不能常态化调用”的商业可持续性。这也意味着,车网互动正在成为一种可以每天发生的“交易”。车主在低谷期充电、高峰期放电,赚取峰谷差价;电网在需要时获得灵活调节能力;充电场站获得基础放电补贴收益。三方各取所需,市场化闭环正在形成。值得一提的是,得益于国网杭州供电公司在迎峰度夏之前按期投运17项主网建设、28项配网重点工程建设,今年杭州迎峰度夏电力供应整体平稳有序。

D | 在这一背景下推进车网互动常态化其实有着更多战略考量,即探索新能源汽车作为分布式储能资源参与电网柔性调节的新路径,为新型电力系统建设积累经验。三年来,国网杭州供电公司通过多地规模化联动、多车型覆盖、常态化运营,正构建起市场化、可复制、可推广的车网互动新模式。

E | 车主通过“e充电”App签约V2G功能,即可参与反向放电,响应结束后系统自动结算。“目前杭州供电公司在全域布点11处V2G站,共35台V2G桩。

F | 下一步,公司将持续在全市加密V2G充电桩布局,在原有示范站点基础上,向主城区核心商圈、大型居民社区、交通枢纽等场景延伸,不断扩大V2G示范站点覆盖范围。”国网杭州供电公司营销部相关工作人员茅奕晟介绍。据了解,该公司计划2027年在全市范围内再增5个示范站点,共计61个V2G桩;同时持续迭代优化V2G技术体系与平台服务功能,在车主已可完成签约、参与响应、自动结算的基础上,进一步优化响应调度算法、提升结算效率、丰富互动场景。
Current article:http://www.chenzhuaigecoupuhongyuntuizei.sbs/m0icgw/rpt.xlsx
Published on:11:13:58